Phathom Share Price

Phathom Share Price

NASDAQ: PHAT | Small Cap | Healthcare
$5.22
-$0.26 (-4.74%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Phathom Stock Performance

Open
$5.29
Prev. Close
$5.48
Circuit Range
N/A
Day Range
$5.04 - $5.32
Year Range
$5.04 - $18.25
Volume
54,459
Average Traded
$5.15

Phathom Share Price Today

As of 19 November 2026, Phathom Pharmaceuticals, Inc.'s share price is $5.22. The stock opened at $5.29, compared to its previous close of $5.48. During today's trading session, Phathom Pharmaceuticals, Inc.'s share price traded between $5.04 and $5.32, with an average price of $5.18. Over the past 52 weeks, the stock has recorded a high of $18.25 and a low of $5.04. In terms of performance, Phathom Pharmaceuticals, Inc.'s share price has declined by 45.63% over the last six months and is down 66.71% on a year-on-year basis.

Phathom Share Price Chart

Line chart of the Phathom price trend over the selected period. The price fell overall, ranging from 5.04 to 5.54, ending at 5.22.
$5.04$5.32
L
Show Current Price
H

Phathom Stock Fundamentals & Key Indicators

Market Cap
$380.64M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.02
Revenue (TTM)
$175.11B
Return On Equity (TTM)
23.87%
Profit Margin
-126.35%
Debt to Equity
-0.48
Quarterly Earnings Growth YoY
34.28%

Phathom Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$57.58$58.30$74.27$84.72
Net Profit-$21.15-$30.37-$17.58-$13.90
Net Profit Margin-36.73%-52.09%-23.67%-16.41%
Income ChangeN/A-43.59%42.11%20.93%

Phathom Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.68$55.25$175.11
Net Profit-$197.72-$201.59-$334.33-$221.25
Net Profit MarginN/A-29645.59%-605.12%-126.35%
Income ChangeN/A-1.96%-65.85%33.82%

Phathom Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets30.1818.1816.414.3
Current Assets228.97360.13397.43160.51
Total Assets259.15378.32413.84164.81
Non Current Liabilities565.27546.17447.82213.39
Current Liabilities132.0485.7338.7826.24
Total Liabilities697.32631.9486.6239.62
Shareholders' Equity-438.17-253.58-72.76-74.81

Phathom Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-166.78-266.77-137.58-146.53
Investing-0.23-0.14-1.63-1.04
Financing-0.29182.77367.58120.04

About Phathom

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Phathom Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$5.75
$5.22
-8.98%
Oct 2026
$7.26
$5.74
-21.65%
Sep 2026
$9.62
$7.32
-18.07%
Aug 2026
$8.71
$8.94
+0.56%
Jul 2026
$10.91
$8.88
-18.19%
Jun 2026
$9.57
$10.86
+13.12%
May 2026
$11.44
$9.60
-13.86%
Apr 2026
$11.29
$11.14
+0.13%
Mar 2026
$12.09
$11.13
-11.42%
Feb 2026
$13.83
$12.56
-8.15%
Jan 2026
$16.52
$13.68
-17.59%
Dec 2025
$15.33
$16.60
+5.87%

Phathom Share Price FAQs